Vitamin D and non-Hodgkin lymphomas, trends from an Italian monocentric studyMassimiliano Postorino, Maria Cantonetti, Renato Massoud et al.|Panminerva Medica|2021Cited by 2
CD49d expression is included in a revised 4‐factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real‐world experienceRiccardo Bomben, Valter Gattei, Tamara Bittolo et al.|HemaSphere|2024Cited by 1
CD49d Expression Is Included in a Revised 4-Factor Model Predicting Outcome in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Multi-Center Real-World ExperienceRiccardo Bomben, Valter Gattei, Antonella Zucchetto et al.|Blood|2023Cited by 0
Baseline Characteristics from CLL-ZANU2024, an Italian Non-Interventional Study Assessing the Real-World Use of Zanubrutinib in the Treatment of Patients with Chronic Lymphocytic Leukemia (CLL)Enrica Antonia Martino, Federico Vozzella, Raffaella Pasquale et al.|Blood|2024Cited by 0